DK1725526T3 - Fremgangsmåde til fremstilling af pyrrolidinoximer - Google Patents

Fremgangsmåde til fremstilling af pyrrolidinoximer

Info

Publication number
DK1725526T3
DK1725526T3 DK05708062T DK05708062T DK1725526T3 DK 1725526 T3 DK1725526 T3 DK 1725526T3 DK 05708062 T DK05708062 T DK 05708062T DK 05708062 T DK05708062 T DK 05708062T DK 1725526 T3 DK1725526 T3 DK 1725526T3
Authority
DK
Denmark
Prior art keywords
pyrrolidinoximes
preparation
formula
dysmenorrhea
prevention
Prior art date
Application number
DK05708062T
Other languages
Danish (da)
English (en)
Inventor
William Nadler
Doris Pupowicz
Original Assignee
Serono Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Serono Lab filed Critical Serono Lab
Application granted granted Critical
Publication of DK1725526T3 publication Critical patent/DK1725526T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06Antiabortive agents; Labour repressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Reproductive Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK05708062T 2004-02-26 2005-02-28 Fremgangsmåde til fremstilling af pyrrolidinoximer DK1725526T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04100773 2004-02-26
PCT/EP2005/050852 WO2005082848A2 (en) 2004-02-26 2005-02-28 Method for preparing pyrrolidine oximes

Publications (1)

Publication Number Publication Date
DK1725526T3 true DK1725526T3 (da) 2008-03-03

Family

ID=34896105

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05708062T DK1725526T3 (da) 2004-02-26 2005-02-28 Fremgangsmåde til fremstilling af pyrrolidinoximer

Country Status (21)

Country Link
US (1) US20070197794A1 (ko)
EP (1) EP1725526B1 (ko)
JP (1) JP2007524702A (ko)
KR (1) KR20060124775A (ko)
CN (1) CN1946686A (ko)
AT (1) ATE380792T1 (ko)
AU (1) AU2005217153A1 (ko)
BR (1) BRPI0508059A (ko)
CA (1) CA2554767A1 (ko)
CY (1) CY1107139T1 (ko)
DE (1) DE602005003803T2 (ko)
DK (1) DK1725526T3 (ko)
EA (1) EA011026B1 (ko)
ES (1) ES2296137T3 (ko)
IL (1) IL177388A0 (ko)
NO (1) NO20064352L (ko)
PL (1) PL1725526T3 (ko)
PT (1) PT1725526E (ko)
SI (1) SI1725526T1 (ko)
UA (1) UA86226C2 (ko)
WO (1) WO2005082848A2 (ko)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2845850A1 (en) * 2013-09-10 2015-03-11 ObsEva S.A. Pyrrolidine derivatives as oxytocin/vasopressin V1a receptors antagonists
EP2886107A1 (en) 2013-12-17 2015-06-24 ObsEva S.A. Oral formulations of pyrrolydine derivatives
EP3753921A1 (en) 2014-07-02 2020-12-23 ObsEva S.A. Crystalline (3z,5s)-5-(hydroxymethyl)-1-[(2'-methyl-1,1'-biphenyl-4-yl)carbonyl]pyrrolidin-3-one o-methyloxime useful in methods of treating conditions related to the ot-r activity
WO2021165927A1 (en) * 2020-02-21 2021-08-26 Wockhardt Bio Ag 2-cyanopyrroldines, -piperidines or -dazepines as hyperglycemic agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6329418B1 (en) * 1998-04-14 2001-12-11 The Procter & Gamble Company Substituted pyrrolidine hydroxamate metalloprotease inhibitors
MXPA02009382A (es) * 2000-03-27 2003-01-28 Applied Research Systems Derivados de pirrolidina farmaceuticamente activos.
BR0211030A (pt) * 2001-06-18 2004-06-22 Applied Research Systems Derivado de pirrolidina oxadiazole, uso de um derivado de pirrolidina oxadiazole, composição farmacêutica contendo pelo menos um derivado de pirrolidina oxadiazole, método para preparação de um composto de pirrolidina oxadiazole

Also Published As

Publication number Publication date
EP1725526A2 (en) 2006-11-29
EA200601456A1 (ru) 2007-02-27
EP1725526B1 (en) 2007-12-12
UA86226C2 (en) 2009-04-10
ATE380792T1 (de) 2007-12-15
DE602005003803D1 (de) 2008-01-24
US20070197794A1 (en) 2007-08-23
JP2007524702A (ja) 2007-08-30
WO2005082848A3 (en) 2005-12-01
CN1946686A (zh) 2007-04-11
KR20060124775A (ko) 2006-12-05
PT1725526E (pt) 2007-12-27
IL177388A0 (en) 2006-12-10
BRPI0508059A (pt) 2007-07-17
NO20064352L (no) 2006-09-26
PL1725526T3 (pl) 2008-03-31
CY1107139T1 (el) 2012-10-24
AU2005217153A1 (en) 2005-09-09
DE602005003803T2 (de) 2008-12-24
WO2005082848A2 (en) 2005-09-09
CA2554767A1 (en) 2005-09-09
ES2296137T3 (es) 2008-04-16
EA011026B1 (ru) 2008-12-30
SI1725526T1 (sl) 2008-04-30

Similar Documents

Publication Publication Date Title
NO20082673L (no) Nye 2-amino-imidazol-4-on forbindelser og deres anvendelse i fremstilling av et medikament som skal brukes til behandling av kognitiv svekkelse, Alzheimers sykdom, neurodegenerasjon og demens
DE602006010433D1 (de) Für die behandlung von obesitas geeignete tricyclische amidderivate
DE602005019078D1 (de) Piperidine und verwandte verbindungen zur behandlung von alzheimer-krankheit
TW200628463A (en) Heteroaryl compounds
UA96971C2 (ru) Способ получения фторметилзамещенных гетероциклических соединений
NO20053890L (no) Syntese av 4-amino-2-butenolklorider og anvendelse derav for fremstilling av 3-cyanokinoliner
ATE490253T1 (de) Synthese von 5-substituierten 7-azaindolen und 7- azaindolinen
DE502005008057D1 (de) Substituierte cyclopenten-verbindungen
NO20062021L (no) Omleirede pentanoler, fremgangsmpte for fremstilling av dette, og deres anvendelse som antiflogistika
CY1116885T1 (el) Υποκατεστημενα παραγωγα κυκλοεξυλομεθυλιου
NO20080394L (no) N-(arylalkyl)-1H-pyrrolopyridin-2-karboksamidderivater, fremstilling og anvendelse derav
NO20082749L (no) Fremgangsmate for fremstilling av ferri-succinylkasein
CY1111327T1 (el) Υποκατεστημενα παραγωγα κυκλοεξυλοξεικου οξεος
NO20071254L (no) Fremgangsmate for fremstilling av irbesartan og mellomprodukter derav.
WO2006020348A3 (en) Polymorphs of atomoxetine hydrochloride
MX2007007446A (es) Procesos para la produccion de 4-aminoquinazolinas.
ES2333026T3 (es) Derivados de ciclohexil-1,4-diamina sustituidos.
DK1725526T3 (da) Fremgangsmåde til fremstilling af pyrrolidinoximer
NO20070550L (no) Fremgangsmate for fremstilling av pyrrolotriazinforbindelser
DE502005009501D1 (de) Verfahren zur herstellung von candesartan
MX2008000821A (es) Nuevos derivados de piperidina.
NO20050980L (no) Mikrobiologisk fremgangsmate for fremstilling av 7a-substituerte 11a-hydroksysteroider
ATE473213T1 (de) Verfahren zur herstellung von phenyl-2- pyrimidinyl-ketonen und neuen zwischenprodukten daraus
SE0400925D0 (sv) Chemical compounds
WO2006074873A3 (en) New one-step synthesis of useful disubstituted amines